Delivery Order SPE2DB22D1106-SPE2DB25FFCG2
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ephedrine Sulfate 50 mg/mL in vial form. The contract is valued at $2,127.78 and carries a firm fixed price structure with an ultimate completion date of August 18, 2025. This award represents a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Ephedrine Sulfate 25 mg/5 mL syringes with a contract ceiling value of $1,916.94 and an ultimate completion date of April 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,074.55, is for the delivery of 4,564,060,192 milliliters of Ephedrine Sulfate 50 mg/mL to support military treatment programs and facilities. This delivery order is part of a broader indefinite delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,482.14, is for the delivery of Ephedrine Sulfate 50 mg/mL injectables. It is a firm fixed-price contract with an ultimate completion date of April 3, 2025. The contract is not set-aside and was open to full and open competition. AmerisourceBergen Drug Corp holds a substantial...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ephedrine Sulfate, a pharmaceutical product, with a ceiling value of $1,469.52 and an ultimate completion date of April 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- The Defense Logistics Agency awarded a $2,168.54 delivery order to AmerisourceBergen Drug Corp for EMERPHED 25 MG/5 ML syringes (5 ML) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,897.90 and is for the delivery of EPHEDRINE SULFATE 50 MG/ML VLML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of October 20, 2023. This award is not designated as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ephedrine Sulfate 50 mg/ml vials. The contract has a firm-fixed-price of $1,066.32 and runs through September 27, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 Firm Fixed Price Delivery Order is for the supply of 4566136258 - Ephedrine Sulfate 50 mg/mL, with a completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for EMERPHED 50 mg/10 mL vials with a ceiling value of $1,390.95 and a firm fixed price structure. This non-set-aside competitive award is classified as a delivery order, with ultimate completion scheduled for August 11, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the pharmaceutical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCG2Delivery Order
The Defense Logistics Agency awarded a $4,987.18 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ephedrine Sulfate 50 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of August 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made without set-aside designation, indicating open competition. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 prime vendor IDC (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare systems. The contract enables the company to supply a wide range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare entities. AmerisourceBergen's established role as a critical federal pharmaceutical distributor, combined with its extensive portfolio of competitively awarded contracts with DLA, reflects the company's capability to fulfill specialized medical supply requirements for the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/8/25 |